Electroconvulsive Therapy Safe, Effective for Range of Serious Mental Illnesses
By Lori Solomon HealthDay Reporter
FRIDAY, April 26, 2024 -- Electroconvulsive therapy (ECT) is a safe and effective treatment for serious mental illness, according to a study presented at the annual congress of the European Psychiatric Association, held from April 6 to 9 in Budapest, Hungary.
Julie Langan Martin, M.B., Ch.B., from the University of Glasgow in the United Kingdom, and colleagues explored the use of ECT across Scotland and its efficacy and side effects for a range of common psychiatric disorders, including depression, bipolar depression, schizophrenia, and mania (2009 to 2019).
The researchers identified 4,826 ECT episodes, mostly in women (68.4 percent). The mean number of treatments per episode was 9.59 and the mean treatment dose delivered was 277.75 mC. Of the 2,920 episodes of treatment with Clinical Global Index Severity (CGI-S) entry and exit recorded, at exit, mean CGI-S scores indicated borderline illness (2.07) compared with marked illness (5.03) at entry. Complications included anesthetic issues and prolonged seizures (<1 percent of treatment episodes for both), as well as cardiovascular problems (2.2 percent), nausea (7.2 percent), and muscle aches (12 percent). Confusion or cognitive side effects were reported in 33.1 percent of treatment episodes.
"[This study] challenges common misconceptions and stigmas associated with ECT, providing valuable insights that can reshape public perceptions and stimulate informed discussions among health care professionals," Julian Beezhold, M.B., Ch.B., the secretary general of the European Psychiatric Association, said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
GLP-1 Receptor Agonist Use Increases Likelihood of Antidepressant Prescription
WEDNESDAY, May 15, 2024 -- Individuals taking glucagon-like peptide (GLP)-1 receptor agonists have a greater risk for subsequently being dispensed antidepressants, according to a...
Child Maltreatment Linked to Externalizing, Internalizing Behavior
TUESDAY, May 14, 2024 -- Child maltreatment is associated with increases in externalizing and internalizing behaviors, according to a study published online May 14 in...
American Psychiatric Association, May 4-8
The annual meeting of the American Psychiatric Association was held from May 4 to 8 in New York City, drawing participants from around the world, including clinicians...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.